Immune response gene profiles in the term placenta depend upon maternal muscle mass

Reproductive Sciences

Volumn 19, Issue 10, 2012, Pages 1041-1056

  O'Tierney, P F ^a   Lewis, R M ^b   McWeeney, S K ^a   Hanson, M A ^b   Inskip, H M ^c   Morgan, T K ^d   Barker, D J ^a   Bagby, G ^a   Cooper, C ^b,c   Godfrey, K M ^b,c   Thornburg, Kent L ^a,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

immune response; muscle mass; placenta

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE BINDING PROTEIN FAMILY MEMBER 6; INTERFERON ALPHA INDUCIBLE PROTEIN 27; INTERFERON INDUCIBLE PROTEIN 35; INTERFERON REGULATORY FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARM MUSCLE; ARM MUSCLE AREA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MATERNAL MUSCLE MASS; MUSCLE MASS; NORMAL HUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; TERM BIRTH;

ARM; COHORT STUDIES; FEMALE; HUMANS; IMMUNITY; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; MALE; MEMBRANE PROTEINS; MUSCLE, SKELETAL; ORGAN SIZE; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION; THINNESS; TRANSCRIPTOME;

EID: 84871559928     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112440051     Document Type: Article

References (42)

1. Eriksson J, Forsen T, Tuomilehto J, Osmond C, Barker D. Size at birth, fat-free mass and resting metabolic rate in adult life. Horm Metab Res. 2002 ; 34 (2). 72-76
2. Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993 ; 36 (1). 62-67
3. Baker J, Workman M, Bedrick E, Frey MA, Hurtado M, Pearson O.. Brains versus brawn: an empirical test of Barker's brain sparing model. Am J Hum Biol. 2010 ; 22 (2). 206-215
4. Jansson N, Pettersson J, Haafiz A, et al. Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol. 2006 ; 576 (Pt 3). 935-946
5. Shiell AW, Campbell DM, Hall MH, Barker DJ. Diet in late pregnancy and glucose-insulin metabolism of the offspring 40 years later. BJOG. 2000 ; 107 (7). 890-895
6. Mi J, Law C, Zhang KL, Osmond C, Stein C, Barker D. Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med. 2000 ; 132 (4). 253-260
7. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008 ; 29 (3). 274-281
8. Jones HN, Woollett LA, Barbour N, Prasad PD, Powell TL, Jansson T. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 2009 ; 23 (1). 271-278
9. Roberts VH, Smith J, McLea SA, Heizer AB, Richardson JL, Myatt L. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta. 2009 ; 30 (2). 169-175
10. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab. 2007 ; 92 (3). 969-975
11. Lewis RM, Greenwood SL, Cleal JK, et al. Maternal muscle mass may influence system A activity in human placenta. Placenta. 2010 ; 31 (5). 418-422
12. Inskip HM, Godfrey KM, Robinson SM, et al. Cohort profile: The Southampton Women's Survey. Int J Epidemiol. 2006 ; 35 (1). 42-48
13. Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr. 1982 ; 36 (4). 680-690
14. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995 ; 57 (1). 289-300
15. Beissbarth T, Speed TP. GOstat: find statistically overrepresented gene ontologies within a group of genes. Bioinformatics. 2004 ; 20 (9). 1464-1465
16. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 2003 ; 19 (3). 368-375
17. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005 ; 115 (3). e290 - e296
18. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009 ; 32 (6). 1076-1080
19. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003 ; 52 (12). 2951-2958
20. Sitras V, Paulssen RH, Gronaas H, et al. Differential placental gene expression in severe preeclampsia. Placenta. 2009 ; 30 (5). 424-433
21. Mestan K, Yu Y, Matoba N, et al. Placental inflammatory response is associated with poor neonatal growth: preterm birth cohort study. Pediatrics. 2010 ; 125 (4). e891 - e898
22. Salafia CM, Ernst LM, Pezzullo JC, Wolf EJ, Rosenkrantz TS, Vintzileos AM. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol. 1995 ; 12 (2). 106-110
23. Tayade C, Fang Y, Croy BA. A review of gene expression in porcine endometrial lymphocytes, endothelium and trophoblast during pregnancy success and failure. J Reprod Dev. 2007 ; 53 (3). 455-463
24. Murphy SP, Tayade C, Ashkar AA, Hatta K, Zhang J, Croy BA. Interferon gamma in successful pregnancies. Biol Reprod. 2009 ; 80 (5). 848-859
25. Roberts KA, Riley SC, Reynolds RM, et al. Placental structure and inflammation in pregnancies associated with obesity. Placenta. 2011 ; 32 (3). 247-254
26. Ravelli AC, van der Meulen JH, Michels RP, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet. 1998 ; 351 (9097). 173-177
27. Kroger A, Koster M, Schroeder K, et al. Activities of IRF-1. J Interferon Cytokine Res. 2002 ; 22 (1). 5-14
28. Murphy SP, Choi JC, Holtz R. Regulation of major histocompatibility complex class II gene expression in trophoblast cells. Reprod Biol Endocrinol. 2004 ; 2 (5). 52
29. Mor G. Inflammation and pregnancy: the role of toll-like receptors in trophoblast-immune interaction. Ann N Y Acad Sci. 2008 ; 1127(1): 121-128
30. Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature. 1998 ; 391 (6665). 410-413
31. Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005 ; 434 (7030). 243-249
32. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011 ; 12 (3). 231-238
33. Nguyen VT, Benveniste EN. Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J Biol Chem. 2000 ; 275 (31). 23674-23684
34. Nareika A, Sundararaj KP, Im YB, Game BA, Lopes-Virella MF, Huang Y. High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity. Atherosclerosis. 2009 ; 202 (2). 363-371
35. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third national health and nutrition examination survey. J Clin Endocrinol Metab. 2011 ; 96 (9). 2898-2903
36. Roos S, Jansson N, Palmberg I, et al. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol. 2007 ; 582 (pt 1). 449-459
37. Roos S, Powell TL, Jansson T. Placental mTOR links maternal nutrient availability to fetal growth. Biochem Soc Trans. 2009 ; 37 (pt 1). 295-298
38. Roos S, Kanai Y, Prasad PD, Powell TL, Jansson T. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am J Physiol Cell Physiol. 2009 ; 296 (1). C142 - C150
39. Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003 ; 17 (15). 1829-1834
40. Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med. 2009 ; 47 (4). 344-356
41. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004 ; 122 (4). 369-382
42. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, Myatt L. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care. 1998 ; 21 (10). 1753-1758